These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10216416)

  • 1. The safety of pharmaceutical excipients.
    de Jong HJ
    Therapie; 1999; 54(1):11-4. PubMed ID: 10216416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Excipients: regulatory aspects].
    Artiges A
    Therapie; 1999; 54(1):15-9. PubMed ID: 10216417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vendor qualification for pharmaceutical excipients--GMP requirements and approach.
    Patel KT; Chotal NP
    Pharmazie; 2010 Nov; 65(11):783-90. PubMed ID: 21155382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical excipient development: the need for preclinical guidance.
    Baldrick P
    Regul Toxicol Pharmacol; 2000 Oct; 32(2):210-8. PubMed ID: 11067777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What are excipients doing in medicinal products?
    Drug Ther Bull; 2009 Jul; 47(7):81-4. PubMed ID: 19567843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excipients in medicinal products used in gastroenterology as a possible cause of side effects.
    Ursino MG; Poluzzi E; Caramella C; De Ponti F
    Regul Toxicol Pharmacol; 2011 Jun; 60(1):93-105. PubMed ID: 21354240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach to the safety assessment of pharmaceutical excipients. The Safety Committee of the International Pharmaceutical Excipients Council.
    Steinberg M; Borzelleca JF; Enters EK; Kinoshita FK; Loper A; Mitchell DB; Tamulinas CB; Weiner ML
    Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 1):149-54. PubMed ID: 8933628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution and challenges for the international harmonization of the regulation of pharmaceutical excipients in Taiwan.
    Chang LC; Kang JJ; Gau CS
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):947-52. PubMed ID: 26387930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ingredients in pharmaceutical preparations: a problem not value.
    Lubner GC
    Boll Chim Farm; 2002; 141(5):332. PubMed ID: 12481372
    [No Abstract]   [Full Text] [Related]  

  • 10. Food allergens submitted to compulsory food labelling in the 50 highest-selling drugs in France.
    Piney D; Commun N; Kanny G
    Eur Ann Allergy Clin Immunol; 2005 Oct; 37(8):309-13. PubMed ID: 17066649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing the microbiological quality of pharmaceutical excipients.
    Cundell AM
    PDA J Pharm Sci Technol; 2005; 59(6):381-95. PubMed ID: 16471425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are pharmaceuticals potent environmental pollutants? Part II: environmental risk assessments of selected pharmaceutical excipients.
    Carlsson C; Johansson AK; Alvan G; Bergman K; Kühler T
    Sci Total Environ; 2006 Jul; 364(1-3):88-95. PubMed ID: 16260028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Overview of Pharmaceutical Excipients: Safe or Not Safe?
    Abrantes CG; Duarte D; Reis CP
    J Pharm Sci; 2016 Jul; 105(7):2019-26. PubMed ID: 27262205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
    Chen ML
    Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives.
    Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of instrumental colour measurement in development and quality control of drugs and pharmaceutical excipients.
    Subert J; Cizmárik J
    Pharmazie; 2008 May; 63(5):331-6. PubMed ID: 18557414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excipients and additives: hidden hazards in drug products and in product substitution.
    Napke E; Stevens DG
    Can Med Assoc J; 1984 Dec; 131(12):1449-52. PubMed ID: 6498699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and regulatory review of dyes commonly used as excipients in pharmaceutical and nutraceutical applications.
    Pérez-Ibarbia L; Majdanski T; Schubert S; Windhab N; Schubert US
    Eur J Pharm Sci; 2016 Oct; 93():264-73. PubMed ID: 27531552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of excipients--a Food and Drug Administration perspective.
    Osterberg RE; See NA
    Int J Toxicol; 2003; 22(5):377-80. PubMed ID: 14555410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.